InGeneron Cell Therapy in Rotator Cuff Repair – Study Results

InGeneron reports favorable results using regenerative cells isolated from patients’ own body fat and prepared with the Transpose® RT System for the treatment of symptomatic partial-thickness rotator cuff tears (sPTRCT).

The FDA-approved, prospective, multicenter, randomized controlled feasibility study is the first randomized controlled trial...

document icon

You are out of free articles for this month

Subscribe as a Guest for $0 and unlock a total of 5 articles per month.

You are out of five articles for this month

Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.


Julie Vetalice is ORTHOWORLD's Editorial Assistant. She has covered the orthopedic industry for over 20 years, having joined the company in 1999.

Contact Us